C3i to provide technical support for Xbiotech monoclonal antibody clinical trial

XBiotech’s True Human monoclonal antibody, which blocks pathologic inflammatory responses, is being developed to treat diseases such as cancer, atherosclerosis and diabetes.

C3i provides a solution to meet the needs of Xbiotech through its proprietary help desk support and end user training systems, in conjunction with Oracle’s Clinical and Remote Data Capture clinical data management system.

C3i will provide XBiotech with global site training and support services to enable participating clinical sites to become proficient in the use of Oracle Remote Data Capture, a data capture solution that allows clinical site personnel to collect study patients’ data at the investigator site and facilitates higher quality data.

Xbiotech MD Michael Stecher said C3i’s services, combined with Oracle Health Sciences solutions, provide them with the opportunity to manage their clinical data in a top-tier system, that is hosted and operated with expertise and experience.